Back to mobile site

Canaccord Reiterates Buy Rating on STAAR Surgical (STAA)

July 16, 2026 4:54 PM EDT Send to a Friend
Canaccord analyst John Young reiterated a Buy rating and $32.00 price target on STAAR Surgical (NASDAQ: STAA).The analyst commented: "STAAR ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login